Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,874 | 16,635 | 16,473 | 14,788 | 10,798 |
| Depreciation Amortization | 2,846 | 6,368 | 7,082 | 7,284 | 7,209 |
| Income taxes - deferred | -359 | -693 | -401 | -92 | -26 |
| Accounts receivable | -835 | 2,270 | -511 | -1,088 | 617 |
| Accounts payable and accrued liabilities | -73 | -456 | 464 | -23 | -308 |
| Other Working Capital | -1,803 | -233 | -2,226 | -1,006 | 1,993 |
| Other Operating Activity | 1,181 | -1,610 | 266 | 1,340 | -146 |
| Operating Cash Flow | $14,831 | $22,281 | $21,147 | $21,203 | $20,137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -230 | -639 | -809 | -552 | -860 |
| Sale Of Investment | 27 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -5 | N/A | -9 | N/A | N/A |
| Other Investing Activity | -5 | 0 | -9 | 0 | 0 |
| Investing Cash Flow | $-208 | $-639 | $-818 | $-552 | $-860 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 390 | 117 | 174 | 560 | 358 |
| Common Stock Repurchased | -19,968 | N/A | -2,495 | N/A | -6,976 |
| Dividend Paid | -4,260 | -4,282 | -3,163 | -11,465 | -4,116 |
| Financing Cash Flow | $-23,838 | $-4,165 | $-5,484 | $-10,905 | $-10,734 |
| Exchange Rate Effect | -677 | 339 | -767 | -362 | 260 |
| Beginning Cash Position | 92,868 | 75,052 | 60,974 | 51,590 | 42,787 |
| End Cash Position | 82,976 | 92,868 | 75,052 | 60,974 | 51,590 |
| Net Cash Flow | $-9,892 | $17,816 | $14,078 | $9,384 | $8,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,831 | 22,281 | 21,147 | 21,203 | 20,137 |
| Capital Expenditure | -230 | -639 | -809 | -552 | -860 |
| Free Cash Flow | 14,601 | 21,642 | 20,338 | 20,651 | 19,277 |